Sriram Ryali - Chief Financial Officer, Eiger Biopharmaceuticals, Inc

As of July 30, 2021


Sriram Ryali Net Worth

  • Net worth is estimated to be at least $12.86K
  • Owns at least 1,250 units of Eiger Biopharmaceuticals, Inc stock

Sriram Ryali Compensation at Eiger Biopharmaceuticals, Inc in 2020

  • Earned a $381,550 salary
  • Received a total compensation of $801,559

Sriram Ryali Trading

  • Largest purchase of shares was 1,250 units , worth over $13.85K on April 22, 2019
  • In total has made about 7 transactions over 2 years
  • Usually trades in March, with the busiest year in 2019 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sriram Ryali Mailing Address

  • Mailing address is C/o Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306 CA

Eiger Biopharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David A. Cory 2020 $590,584 - - $829,564 $393,360 $16,671 $1,830,179
David A. Cory 2019 $565,833 - - $2,009,820 $285,000 $11,200 $2,871,853
Sriram Ryali 2020 $381,550 - - $234,442 $173,272 $12,296 $801,559
Sriram Ryali 2019 $335,000 - - $662,211 $117,250 $9,732 $1,124,193
Eldon Mayer 2020 $385,569 $100,000 $92,700 $1,199,520 $169,256 $2,328 $1,949,373
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm

Eiger Biopharmaceuticals, Inc Insider Trading

  • The most recent transaction was 2,500 units bought on April 12, 2021 by John Thomas Dietz worth over $21.22K
  • In the last 5 years, insiders at Eiger Biopharmaceuticals, Inc sold an estimated value of $2.94M and bought an estimated value of $4.61M
  • The most active traders are John Thomas Dietz, Director,  David Cory, President and CEO,  and Eldon Mayer III, Ex VP & Chief Commerc. Officer
  • Insider trading is most common in March, with the busiest year in 2019

Eiger BioPharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1